Company
Aura Biosciences, Inc.
AURA · CIK 0001501796
Acquisition (code A) of 107,611 shares at $0 per share.
Reporting Person Person Julie · Officer Title Chief People Officer · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001946505-26-000009 · filed 2026-09-01 · View filing →
Acquisition (code A) of 58,850 shares at $0 per share.
Reporting Person Hopkins Janet Jill · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001997710-26-000004 · filed 2026-09-01 · View filing →
Acquisition (code A) of 23,540 shares at $0 per share.
Reporting Person Elazzouzi Amy · Officer Title SVP, Finance & PAO · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0002042910-26-000003 · filed 2026-09-01 · View filing →
Acquisition (code A) of 134,513 shares at $0 per share.
Reporting Person Abu-Absi Susan · Officer Title Chief Operating Officer · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0002148701-26-000008 · filed 2026-09-01 · View filing →
Acquisition (code A) of 100,885 shares at $0 per share.
Reporting Person Kratz Erica · Officer Title Chief Reg. & Quality Officer · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0002148785-26-000009 · filed 2026-09-01 · View filing →